[ Carcinosarcome utérin associé au traitement par le Tamoxifène et révélé par des algies pelviennes chroniques: A propos d'un cas et revue de la littérature ]
Volume 10, Issue 2, October 2014, Pages 395–400
Ihssane Hakimi1, Hafsa Chahdi2, Youssef Benabdejlil3, Jaouad Kouach4, Driss Moussaoui5, and Mohammed Dehayni6
1 Service de Gynécologie Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
2 Service d'Anatomie Pathologique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
3 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
4 Faculté de Médecine et de Pharmacie, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
6 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
Original language: French
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Carcinosarcomas are rare uterine cancers and carry poor prognosis. Although these tumours usually arise de novo, some cases developed under tamoxifen therapy have been reported. We report a case of uterine carcinosarcoma occurring in a postmenopausal patient benefiting from tamoxifen therapy as adjuvant treatment of breast cancer.
Author Keywords: Carcinosarcomas, Uterus, Tamoxifen.
Volume 10, Issue 2, October 2014, Pages 395–400
Ihssane Hakimi1, Hafsa Chahdi2, Youssef Benabdejlil3, Jaouad Kouach4, Driss Moussaoui5, and Mohammed Dehayni6
1 Service de Gynécologie Obstétrique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
2 Service d'Anatomie Pathologique, Hôpital Militaire d'Instruction Mohamed V, Rabat, Morocco
3 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
4 Faculté de Médecine et de Pharmacie, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
6 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
Original language: French
Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Carcinosarcomas are rare uterine cancers and carry poor prognosis. Although these tumours usually arise de novo, some cases developed under tamoxifen therapy have been reported. We report a case of uterine carcinosarcoma occurring in a postmenopausal patient benefiting from tamoxifen therapy as adjuvant treatment of breast cancer.
Author Keywords: Carcinosarcomas, Uterus, Tamoxifen.
Abstract: (french)
Les carcinosarcomes sont des cancers rares de l'utérus et leur pronostic est péjoratif. Si ces tumeurs sont le plus souvent primitives, il a été rapporté un certain nombre de cas survenant après une hormonothérapie par tamoxifène. Les auteurs rapportent un cas de carcinosarcome utérin survenue chez une patiente ménopausée ayant eu une hormonothérapie antiestrogénique dans le cadre du traitement adjuvant d'un cancer du sein.
Author Keywords: Carcinosarcomes, Utérus, Tamoxifène.
How to Cite this Article
Ihssane Hakimi, Hafsa Chahdi, Youssef Benabdejlil, Jaouad Kouach, Driss Moussaoui, and Mohammed Dehayni, “Uterine Carcinosarcome associated with tamoxifen therapy and revealed by chronic pelvic pain: A case report and review of the literature,” International Journal of Innovation and Scientific Research, vol. 10, no. 2, pp. 395–400, October 2014.
